Prot#AK002-003: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis

Project: Research project

Project Details

StatusActive
Effective start/end date8/27/188/27/21

Funding

  • Allakos, Inc. (Prot#AK002-003)